LPL Financial’s AbbVie ABBV Stock Holding History

LPL Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,300	Closed	-$409K	–	5345
2024 Q4	$409K	Buy	+2,300	New	+$423K	﹤0.01%	4265

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial's ABBV Position: Q2 2026 in Review

LPL Financial increased its AbbVie (ABBV) stake by 3.8% in Q2 2026, buying an estimated $32.5M and bringing the position to 4,096,323 shares worth $1.03B. The position accounts for 0.23% of the portfolio, ranked #88.

LPL Financial first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LPL Financial held 4,096,323 shares of AbbVie worth $1.03B as of Q2 2026.
LPL Financial bought 151,057 AbbVie shares in Q2 2026, an estimated $32.5M.
AbbVie made up 0.23% of LPL Financial's portfolio in Q2 2026, its #88 holding.
LPL Financial first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.